Drug Shortage Report for PRO-AMOX-250
| Report ID | 175133 |
| Drug Identification Number | 00644331 |
| Brand name | PRO-AMOX-250 |
| Common or Proper name | AMOX 250 |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | AMOXICILLIN |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 150ml |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-11-21 |
| Actual start date | 2022-11-28 |
| Estimated end date | 2023-05-05 |
| Actual end date | 2023-05-05 |
| Shortage status | Resolved |
| Updated date | 2024-02-14 |
| Company comments | under allocation, sous allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.